Dana Investment Advisors Inc. grew its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 41.4% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 82,091 shares of the company’s stock after purchasing an additional 24,041 shares during the period. Dana Investment Advisors Inc.’s holdings in Zoetis were worth $5,121,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of ZTS. CGOV Asset Management boosted its position in shares of Zoetis by 2.7% during the 1st quarter. CGOV Asset Management now owns 169,605 shares of the company’s stock valued at $12,059,000 after purchasing an additional 4,405 shares in the last quarter. Clinton Group Inc. bought a new position in shares of Zoetis during the 1st quarter valued at about $997,000. Victory Capital Management Inc. boosted its position in shares of Zoetis by 738.5% during the 1st quarter. Victory Capital Management Inc. now owns 243,747 shares of the company’s stock valued at $13,008,000 after purchasing an additional 214,676 shares in the last quarter. Sandy Spring Bank boosted its position in shares of Zoetis by 2.1% during the 1st quarter. Sandy Spring Bank now owns 30,930 shares of the company’s stock valued at $1,651,000 after purchasing an additional 648 shares in the last quarter. Finally, Blair William & Co. IL boosted its position in shares of Zoetis by 10.6% during the 1st quarter. Blair William & Co. IL now owns 2,430,593 shares of the company’s stock valued at $129,695,000 after purchasing an additional 232,630 shares in the last quarter. Institutional investors own 93.20% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Dana Investment Advisors Inc. Boosts Stake in Zoetis Inc. (ZTS)” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this report on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The correct version of this report can be read at https://www.watchlistnews.com/dana-investment-advisors-inc-boosts-stake-in-zoetis-inc-zts/1613018.html.

Several research firms have recently weighed in on ZTS. BidaskClub lowered shares of Zoetis from a “hold” rating to a “sell” rating in a research report on Friday. Cantor Fitzgerald restated a “buy” rating and set a $75.00 price objective on shares of Zoetis in a research report on Tuesday, September 26th. Stifel Nicolaus restated a “buy” rating and set a $65.00 price objective on shares of Zoetis in a research report on Friday, September 1st. Piper Jaffray Companies set a $73.00 price objective on shares of Zoetis and gave the company a “buy” rating in a research report on Friday, August 25th. Finally, Cowen and Company set a $70.00 price objective on shares of Zoetis and gave the company a “buy” rating in a research report on Thursday, August 24th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and eleven have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $65.44.

Shares of Zoetis Inc. (NYSE:ZTS) traded up 0.024% on Friday, hitting $63.765. 762,011 shares of the company’s stock traded hands. The company has a market cap of $31.19 billion, a price-to-earnings ratio of 36.046 and a beta of 1.02. The firm’s 50-day moving average price is $63.33 and its 200 day moving average price is $60.42. Zoetis Inc. has a 1-year low of $46.86 and a 1-year high of $65.83.

Zoetis (NYSE:ZTS) last posted its earnings results on Tuesday, August 8th. The company reported $0.53 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.53. The company had revenue of $1.27 billion during the quarter, compared to analyst estimates of $1.27 billion. Zoetis had a return on equity of 62.49% and a net margin of 17.50%. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.49 EPS. On average, equities research analysts expect that Zoetis Inc. will post $2.34 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 1st. Stockholders of record on Thursday, November 9th will be given a dividend of $0.105 per share. This represents a $0.42 annualized dividend and a dividend yield of 0.66%. Zoetis’s payout ratio is currently 23.73%.

Zoetis Company Profile

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.